Health
INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19
PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced it has dosed its first subject in a Phase 2 clinical tr...
2020-12-07 21:00
3417
Merck Expands Life Science Production Capacities in the United States
-- Expansions to significantly increase capacity by end of 2021 to meet unprecedented demand -- Combined expansion of Danvers, Massachusetts, and Jaffrey, New Hampshire, USA facilities to create nearly 700 new positions -- Business sector's announced 2020 investments total more than € 350 millio...
2020-12-07 21:00
2119
PharmAbcine to present new interim data from its ongoing mTNBC trial at SABCS 2020
DAEJEON, South Korea, Dec. 7, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company will present the updated interim data from the ongoing phase Ib trial of olin...
2020-12-07 21:00
1113
JW Therapeutics Presents Data from Pivotal Trial of Relma-cel at the 62nd ASH Annual Meeting
SHANGHAI, Dec. 7, 2020 /PRNewswire/ -- JW Therapeutics (stock code: 2126.HK), a leading clinical stage cell therapy company, presented data from the pivotal study (RELIANCE Trial) of relmacabtagene autoleucel ("relma-cel") under IND pathway at the 62nd American Society of Hematology (ASH) Annual ...
2020-12-07 18:30
2201
The Mullings Group Opens London Office To Service Talent Acquisitions for Growing MedTech Clientele in U.K., EU and Middle East
LONDON, Dec. 7, 2020 /PRNewswire/ -- The Mullings Group, a leading talent acquisition firm in the U.S. specializing in medical & health technology and life sciences, has opened an office inLondon to service the growing needs of its clientele in the U.K., E.U. and theMiddle East. "We experienced ...
2020-12-07 15:00
1200
GEN inCode Appoints Chief Financial Officer
OXFORD, England, Dec. 7, 2020 /PRNewswire/ -- GEN inCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease announces today the appointment of Paul Foulger as Chief Financial Officer to the Company. Paul Foulge...
2020-12-07 15:00
1283
YES Partners with Singapore's Gaia Science
FREMONT, Calif., Dec. 7, 2020 /PRNewswire/ -- YES (Yield Engineering Systems, Inc.), a leading manufacturer of process equipment for semiconductor advanced packaging, Life Science and "More-than-Moore" applications, today announced that it has signed an agreement with Gaia Science Pte. Ltd ofSing...
2020-12-07 09:00
1867
Antengene Announces Acceptance of IND Application in China for ATG-010 (selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study
SHANGHAI and HONG KONG, Dec. 7, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and on...
2020-12-07 08:00
3512
CARsgen Therapeutics Presents Updated Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition
SHANGHAI, Dec. 6, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company, announced updated safety and efficacy results from its ongoing global clinical studies of CT053, an investigational chimeric antigen receptor (CAR) T-cell therapy for patients with relapsed an...
2020-12-06 19:00
3546
Gracell Biotechnologies Announces Presentation of First-in-Human Data of GC012F a First-in-Class FasTCAR-enabled Dual-targeting BCMA/CD19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Multiple Myeloma at 2020 ASH Annual Meeting
SUZHOU and SHANGHAI, China, Dec. 5, 2020 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced an interim readout to evaluat...
2020-12-06 04:30
3258
Issuance of new shares in Mentice AB (publ) has been registered with the Swedish Companies Registration Office
STOCKHOLM, Dec. 5, 2020 /PRNewswire/ -- Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price ofSEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at a subscription price ofSEK ...
2020-12-05 00:35
5407
I-Mab Accelerates Clinical Development of Anti-CD47 Monoclonal Antibody Lemzoparlimab in the US and China
SHANGHAI and GAITHERSBURG, Md., Dec. 4, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics, today announced the advancement of clinical dev...
2020-12-04 21:00
8229
Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch
INCHEON, South Korea, Dec. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced the launch of a virtual showroom to provide key features and real-time construction updates of its recently announced Plant 4. The digital showcase also highlights various specs and services that the S...
2020-12-04 20:00
2215
Indonesia's Government to Continue Improving Competitiveness in Human Capital Against the Backdrop of the Fourth Industrial Revolution and the Demographic Dividend
JAKARTA, Indonesia, Dec. 4, 2020 /PRNewswire/ -- In addition to accelerating national economic recovery in the midst of the Covid-19 pandemic,Indonesia's government continues to support efforts in improving human capital competitiveness. This is done in order to better prepare them in facing the ...
2020-12-04 17:01
2127
Polygiene and Eye-care innovator Body Doctor now increase the range of soothing eye compresses and face masks
STOCKHOLM, Dec. 4, 2020 /PRNewswire/ -- Body Doctor specializes in eye-care, eyelid hygiene products and have transformed the market for eye compresses and continue establishing a pedigree of bringing innovation to the sector with an antibacterial fabric thanks to the partnership with Polygiene®....
2020-12-04 16:23
2448
Ascentage Pharma Appoints Mr. Gang Zhu as Chief Commercial Officer to Lead Commercial Initiatives
SUZHOU, China and ROCKVILLE, Md., Dec. 4, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced the appointment of Mr. Gang Z...
2020-12-04 08:28
2341
Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab) is Safe and Well Tolerated in Phase IIa HBV Study
HANGZHOU and SHAOXING, China, Dec. 4, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) announces today that Phase IIa data demonstrated that ASC22 (Envafolimab) is safe and well tolerated in chronic hepatitis B (CHB) patients and Phase IIb clinical trial has been initiated. ASC22 (Envafolima...
2020-12-04 08:00
3493
I Peace, Inc. Obtains IRB Approval for Production of Clinical and Research-Grade iPSCs for Commercial Use
PALO ALTO, Calif., Dec. 3, 2020 /PRNewswire/ -- I Peace, Inc., a Palo Alto -based biotech start-up focusing on Nobel Prize-winning induced pluripotent stem cell (iPSC) technology obtains approval from an independent Institutional Review Board (IRB) for the process of generating iPSCs—including...
2020-12-04 05:00
1201
Aspect Imaging Lauded by Frost & Sullivan for Its Revolutionary Embrace® Neonatal MRI System that Addresses the Key Medical Imaging Challenges of Neonatologists
By eliminating the need to move neonates from the NICU to the radiology department, Aspect Imaging's Embrace enables a safer way to perform the MRI procedure LONDON, Dec. 3, 2020 /PRNewswire/ -- Based on its recent analysis of the global neonatal intensive care unit magnetic resonance imaging (I...
2020-12-03 23:40
1892
Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for COVID-19
Highlights: * The first hospitalized patient with severe COVID-19, treated under an eIND was discharged in 5 days after being treated with Silmitasertib. * The first patient with moderate COVID-19 has enrolled into this clinical trial at the Center for Advanced Research and Education (CARE),G...
2020-12-03 22:17
2232
Week's Top Stories
Most Reposted
MediThinQ Unveils SCOPEYE 3D Micro Surgery Solution; Chris Lee of VentureBlick Assumes Chairmanship
[Picked up by 329 media titles]
2024-05-23 10:00
SINGAPORE'S XSQUARE TECHNOLOGIES SECURES S$10.5M IN SERIES A FUNDING LED BY WAVEMAKER PARTNERS
[Picked up by 324 media titles]
2024-05-23 10:00Innomix and World Castle Association Pioneer LBMR project at Zhangbi Fortress
[Picked up by 321 media titles]
2024-05-20 13:48
Samsung Electronics Unveils Month-Long Celebration of Esports Events for Students in Southeast Asia
[Picked up by 320 media titles]
2024-05-21 08:00
Mitsui Bussan Secure Directions, Inc. launches Blackpanda IR Retainer, a cyber incident emergency response retainer service
[Picked up by 310 media titles]
2024-05-21 13:00
Most Read
Innomix and World Castle Association Pioneer LBMR project at Zhangbi Fortress
2024-05-20 13:48
8526
Samsung Electronics Unveils Month-Long Celebration of Esports Events for Students in Southeast Asia
2024-05-21 08:00
7718
Mitsui Bussan Secure Directions, Inc. launches Blackpanda IR Retainer, a cyber incident emergency response retainer service
2024-05-21 13:00
7590
Ferretti's first-quarter performance shines, with the new shipyard put into operation
2024-05-20 07:12
7101
Revolutionising Cardiac Care at Pantai Hospital Kuala Lumpur
2024-05-23 11:22
6679
